HEMISPHERIAN AS
925333409ActiveDeveloping novel small molecule drugs targeting TET2 for aggressive cancers.
Oversigt
- 5
- Medarbejdere
- 269t NOK
- Omsætning
- 2020
- Grundlagt
Nøglebeslutningstagere
Zeno Albisser
Chief Executive Officer
Wolfram Eichner
Director
Adam Robertson
Chief Scientific Officer
Terezia Prikrylova
Chief Operating Officer
+15 flere kontakter i Funnelfeedr
Beskrivelse
Hemispherian is an innovative preclinical pharmaceutical company dedicated to redefining targeted cancer therapeutics. The core focus is developing a novel class of small molecule drugs that specifically target the TET2 enzyme. These compounds are designed as targeted therapies for particularly aggr...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
19 kontakter i FunnelfeedrZeno Albisser
Chief Executive Officer
Wolfram Eichner
Director
Adam Robertson
Chief Scientific Officer
Terezia Prikrylova
Chief Operating Officer
Roger Stupp
Chair of Clinical Advisory Board
Michael Lim
Clinical Advisory Board Member
Peter Suenaert
Clinical Development
Monika Hegi
Clinical Advisory Board Member
Paul Lelieveld
Chairman
Frode Vartdal
Director
Dallas Hack
Director
Marek Cichocki
Director Chemistry, Manufacturing and Control
Anna Koptina
Regulatory Affairs Consultant
Einar O. Vik-Mo
Clinical Advisory Board Member
Frans van Dalen
Observer
Isabelle M. Germano
Clinical Advisory Board Member
Andre kontakter
Sandra Cantilena
Senior Scientist
Josipa Matic
Medicinal Chemist (H2020 Funded)
Guro Kristoffersen
Scientist
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
One-carbon Therapeutics AB
4 medarbejdereClinical-stage biotech pioneering novel anti-cancer therapies targeting metabolism.
ONCOSYNE AS
6 medarbejdereDeveloping cancer treatments using patient-derived 3D tumoroid models.
Double Bond Pharmaceutical AB
5–9 medarbejdereDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
OSLO SCIENCE HUB AS
Accelerating cancer treatment development through collaboration and innovation.
EXACT THERAPEUTICS AS
12 medarbejdereClinical-stage company developing ultrasound-mediated targeted therapy enhancement.
Udforsk mere
Spørgsmål om HEMISPHERIAN AS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo